Exparel 133 MG/10 ML vial 10ML

Ended Awarded

Contract number
SPE2DB23FU7NM
Awardee
Awarding agency
Obligated
$3,390

Award facts

Contract value 100% obligated
$3,390.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $3,390 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 133 mg/10 ml vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension used for postsurgical analgesia. Performance will take place in Park Ridge, Illinois over a one-month period concluding in mid-September 2023. No set aside designation or subcontractors were identified. This order is likely associated with DLA's Prime Vendor program to maintain medical product inventory for military treatment facilities worldwide.

Quick answers

Who was awarded contract SPE2DB23FU7NM?

SPE2DB23FU7NM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2023.

How much is contract SPE2DB23FU7NM worth?

The government has obligated $3,390 on SPE2DB23FU7NM.

Is contract SPE2DB23FU7NM an order under another contract?

Yes. SPE2DB23FU7NM is a delivery order under SPE2DB22D9101, an indefinite delivery contract.

Was contract SPE2DB23FU7NM competed?

The extent of competition for SPE2DB23FU7NM was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award